{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:47:31Z","timestamp":1794451651042,"version":"4.9.1"},"publisher-location":"Boston, MA","reference-count":13,"publisher":"Springer US","isbn-type":[{"value":"9781489918277","type":"print"},{"value":"9781489918253","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997]]},"DOI":"10.1007\/978-1-4899-1825-3_130","type":"book-chapter","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T03:33:48Z","timestamp":1373254428000},"page":"563-566","source":"Crossref","is-referenced-by-count":15,"title":["Superantigenic Activity Produced by Group A Streptococcal Isolates is Neutralized by Plasma from IVIG-Treated Streptococcal Toxic Shock Snydrome Patients"],"prefix":"10.1007","author":[{"given":"Anna","family":"Norrby-Teglund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"130_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198707163170305","volume":"3","author":"LA Cone","year":"1987","unstructured":"Cone, LA, Woodard, DR, Schlievert, PM, and Tomory, GS. 1987. Clinical and bacteriological observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med., 3:146\u2013149.","journal-title":"N. Engl. J. Med."},{"key":"130_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198907063210101","volume":"321","author":"DL Stevens","year":"1989","unstructured":"Stevens, DL, Tanner, MH, Winship, J, Swarts, R, Ries. KM, Schlievert, PM, and Kaplan, E. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med., 321:1\u20137.","journal-title":"N. Engl. J. Med."},{"key":"130_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","volume":"269","author":"The Working Group on Severe Streptococcal Infections.","year":"1993","unstructured":"The Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA, 269:390\u20131.","journal-title":"JAMA"},{"key":"130_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.8.3.411","volume":"8","author":"M Kotb","year":"1995","unstructured":"Kotb, M. 1995. Bacterial exotoxins as superantigens. Clin. Microbiol. Rev., 8:411\u2013426.","journal-title":"Clin. Microbiol. Rev."},{"key":"130_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/infdis\/167.5.997","volume":"167","author":"PM Schlievert","year":"1993","unstructured":"Schlievert, PM. 1993. Role of superantigens in human diseases. J. Infect. Dis., 167:997\u20131002.","journal-title":"J. Infect. Dis."},{"key":"130_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1128\/IAI.60.2.701-705.1992","volume":"60","author":"M Tomai","year":"1992","unstructured":"Tomai, M, Schlievert, PM, and Kotb, M. 1992. Distinct T Cell receptor V\u00df Gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and M protein. Infect. Immun., 60:701\u20135.","journal-title":"Infect. Immun."},{"key":"130_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/171.1.74","volume":"171","author":"R Watanabe-Ohnishi","year":"1995","unstructured":"Watanabe-Ohnishi, R, Low, DE, McGeer, A, Stevens, DL, Schlievert, PM, Newton, D, Schwartz, B, Kreiswirth, B, project, Oss, and Kotb, M. 1995. Selective Depletion of V\u00df-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J. Infect. Dis., 171: 74\u201384.","journal-title":"J. Infect. Dis."},{"key":"130_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2249.1994.tb06620.x","volume":"98","author":"C Michie","year":"1994","unstructured":"Michie, C, Scott, A, Cheesbrough, J, Beverley, P, and Pasvol, G. 1994. Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effect on T lymphocyte subsets in vivo. Clin. Exp. Immunol., 98:140\u2013144.","journal-title":"Clin. Exp. Immunol."},{"key":"130_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1172\/JCI116240","volume":"91","author":"S Takei","year":"1993","unstructured":"Takei, S, Arora, YK, and Walker, SM. 1993. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest., 91:602\u20137.","journal-title":"J. Clin. Invest."},{"key":"130_CR10","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/eji.1830240420","volume":"24","author":"U Skansen-Saphir","year":"1994","unstructured":"Skansen-Saphir, U, Andersson, J, Bjork, L, and Andersson, U. 1994. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur. J. Immunol., 24:916\u201322.","journal-title":"Eur. J. Immunol."},{"key":"130_CR11","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","volume":"156","author":"A Norrby-Teglund","year":"1996","unstructured":"Norrby-Teglund, A, Kaul, R, Low, DE, McGeer, A, Andersson, JP, Andersson, UG, and Kotb, M. 1996. Plasma from patients with severe invasive group A streptococcal infections treated with polyspeciflc IgG (IVIG) inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol., 156:3057\u20133064.","journal-title":"J. Immunol."},{"key":"130_CR12","doi-asserted-by":"crossref","unstructured":"Norrby-Teglund, A, Kaul, R, Low, DE. McGeer, A, Andersson, JP, Andersson, UG, and Kotb, M. 1996. Evidence for the presence of streptococcal superantigen neutralizing antibidies in normal polyspecific Ig G (IVIG). Infect. Immun., (in press).","DOI":"10.1128\/IAI.64.12.5395-5398.1996"},{"key":"130_CR13","unstructured":"Kaul, R, McGeer, A, group, Canadian Infectious Disease Society, Norrby-Teglund, A, Kotb, M, and Low, DE. 1995. Intravenous immunoglobulin (IVIG) therapy in streptococcal toxic shock syndrome (STSS): results of a matched case-control study. 35th Interscience conference on antimicrobial agents and chemotherapy, LM68 (Abstr.)."}],"container-title":["Advances in Experimental Medicine and Biology","Streptococci and the Host"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-1825-3_130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T19:17:42Z","timestamp":1688325462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-1825-3_130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"ISBN":["9781489918277","9781489918253"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-1825-3_130","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4899-1825-3","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}